Anne-Marie Dingemans

Erasmus University Rotterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Manuela Joore

University of Maastricht

NETHERLANDS

View details

Gerco den Hartog

National Institute for Public Health and the Environment

NETHERLANDS

View details

Hanneke W. M. van Laarhoven

NETHERLANDS

View details

Esther de Hoop

Erasmus University Rotterdam

NETHERLANDS

View details

Marcel Dijkgraaf

Professor

Amsterdam UMC Locatie VUmc

NETHERLANDS

View details

Elisabeth van Rossum

Erasmus University Rotterdam

NETHERLANDS

View details

Ron Mathijssen

Erasmus University Rotterdam

NETHERLANDS

View details

Inge Henselmans

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anne-Marie Dingemans

Research Interests

Explore related searches

Contact this professor

Articles (10)

Influence of Food With Different Fat Concentrations on Alectinib Exposure

Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

Cost-effectiveness of proton radiotherapy versus photon radiotherapy for non-small cell lung cancer patients

Approach to Alectinib-Induced Body Weight Gain in Patients With ALK+ Non–Small Lung Cancer

Trends in the epidemiology of small-cell lung cancer

Endosonography With or Without Confirmatory Mediastinoscopy for Resectable Lung Cancer

Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer

Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI’s: Exploration of efficacy of unselected treatment in a multicenter cohort study

Real-world treatment patterns and survival of patients with ROS1 rearranged stage IV non-squamous NSCLC in the Netherlands

Collaborators (8)

Manuela Joore

Gerco den Hartog

Hanneke W. M. van Laarhoven

Esther de Hoop

Marcel Dijkgraaf

Elisabeth van Rossum

Ron Mathijssen

Inge Henselmans

Make your next move.